We are live on ! Find out more
NI

Nextech Invest Portfolio holdings

AUM $1.42B
1-Year Est. Return 304.47%
This Fund
S&P 500
This Quarter Est. Return
+13.41%
1 Year Est. Return
+304.47%
3 Year Est. Return
+631.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$294M
AUM Growth
+$54.6M
Cap. Flow
+$28.1M
Cap. Flow %
9.55%
Top 10 Hldgs %
97.8%
Holding
13
New
1
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
ORIC icon
Oric Pharmaceuticals
ORIC
+$24.3M
2
RLAY icon
Relay Therapeutics
RLAY
+$4.02M

Top Sells

Rank Stock Value
1
PMVP icon
PMV Pharmaceuticals
PMVP
+$262K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$38.6B
$129M 44%
4,839,529
– –
TYRA icon
2
Tyra Biosciences
TYRA
$1.84B
$42.9M 14.58%
2,518,582
– –
ORIC icon
3
Oric Pharmaceuticals
ORIC
$1.2B
$33.3M 11.3%
+4,285,714
New +$24.3M
EQRX
4
DELISTED
EQRx, Inc. Common Stock
EQRX
$24.4M 8.28%
13,104,424
– –
CGEM icon
5
Cullinan Oncology
CGEM
$1.04B
$13.1M 4.47%
1,221,145
– –
SPRY icon
6
ARS Pharmaceuticals
SPRY
$573M
$12.8M 4.35%
1,910,029
– –
RLAY icon
7
Relay Therapeutics
RLAY
$3.99B
$11.9M 4.05%
948,659
+323,174
+52% +$4.02M
ARVN icon
8
Arvinas
ARVN
$534M
$7.13M 2.42%
287,251
– –
KNTE
9
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$7.06M 2.4%
2,329,480
– –
THRX
10
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$5.7M 1.94%
611,310
– –
PMVP icon
11
PMV Pharmaceuticals
PMVP
$57.1M
$2.95M 1%
471,284
-50,000
-10% -$262K
KRON
12
DELISTED
Kronos Bio
KRON
$2.5M 0.85%
1,451,537
– –
CCCC icon
13
C4 Therapeutics
CCCC
$391M
$1.03M 0.35%
375,857
– –

Similar funds

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Nextech Invest's Q2 2023 Portfolio in Review

As of Q2 2023, Nextech Invest held 13 positions worth $294M, up 23% from $240M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Nextech Invest deployed $28.1M of net new capital in Q2 2023, opening 1 new position and adding to 1 existing holding. Its largest new stake was Oric Pharmaceuticals: 4,285,714 shares worth $33.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was PMV Pharmaceuticals, an estimated $262K trimmed.

  • Nextech Invest's largest Q2 2023 buy was Oric Pharmaceuticals: 4,285,714 shares worth $33.3M.
  • Nextech Invest added most to Relay Therapeutics in Q2 2023, an estimated $4.02M increase.
  • Nextech Invest's biggest Q2 2023 reduction was PMV Pharmaceuticals, cutting an estimated $262K.
  • Nextech Invest's ten largest holdings make up 98% of its $294M portfolio in Q2 2023.
  • Nextech Invest opened 1 new position and closed 0 in Q2 2023.
  • Nextech Invest's portfolio value rose 23% quarter-over-quarter to $294M.

Based on Nextech Invest's 13F filing for Q2 2023, filed 14 Aug 2023.